Medicus Pharma Ltd. (MDCX) Balance Sheet

NASDAQ: MDCXAssets, liabilities, debt and equity over 7 years.

MDCX balance sheet, 2025

December 31, 2025 · U.S. dollars

$10.1M assets = $10.0M liabilities + $37,311 equity

What it owns$10.1MCash & ST investments: $8.7M (86.5%)Cash & ST investments$8.7M · 87%Other current: $1.2M (11.8%)Other current$1.2M · 12%PP&E: $170,733 (1.7%)=How it is financed$10.1MCurrent liabilities: $9.9M (98.8%)Current liabilities$9.9M · 99%Long-term debt: $25,865 (0.3%)Other LT liabilities: $36,877 (0.4%)Shareholders’ equity: $37,311 (0.4%)

Both columns are drawn to the same scale: what MDCX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

MDCX financial health

Current ratio1.00
Tight · current assets cover current liabilities 1.00×
Equity / assets−0.7%
Thin equity · of assets funded by shareholders
Cash / debt217.9%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

MDCX balance sheet trends, 2010–2025

Medicus Pharma Ltd. balance sheet trends
MetricTrendThenLatestChange
Total assets$3.0M2010$10.1M2025+22.4%/yr
Total liabilities$5.0M2010$10.0M2025+12.3%/yr
Shareholders’ equity−$2.0M2010−$67,5542025—
Cash & short-term investments$5,4102010$8.7M2025+242.3%/yr
Total debt$2.3M2010$4.0M2025+9.6%/yr
Net cash (debt)−$2.3M2010$4.7M2025+$7.0M
Working capital−$1.4M2010−$47,4182025+$1.3M
Current ratio0.6820101.002025+0.31

Change is the average annual growth (CAGR) or the difference between the first and latest year.

MDCX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

MDCX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

MDCX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

MDCX balance sheet

Medicus Pharma Ltd. annual balance sheet
2025202420232022202120172010
Assets
Cash & short-term investments$8.7M$4.2M$1.7M$267,652$78,514$40,583$5,410
Cash & equivalents$8.7M$4.2M$1.7M$267,652$78,514$40,583$5,410
Receivables$0$0$0$0$0$0$1.9M
Inventory$0$0$0$0$0$0$1.1M
Other current assets$1.2M$1.2M$173,719$15,000$0$0$46,230
Total current assets$9.9M$5.4M$1.9M$282,652$78,514$40,583$3.0M
Property, plant & equipment (net)$170,733$268,571$0$0$0$0$0
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$0$0$0$0$0$0$29,130
Total assets$10.1M$5.6M$1.9M$282,652$78,514$40,583$3.0M
Liabilities
Accounts payable$3.4M$1.3M$210,842——$3,234$2.7M
Short-term debt$3.9M$116,323—$1.5M$667,931—$1.7M
Total current liabilities$9.9M$2.3M$781,609$12.5M$10.6M$3,234$4.4M
Long-term debt$25,865$0$0$0$0$0$644,185
Lease obligations$205,595$322,268$0————
Other long-term liabilities$36,877$205,945$0$0$0$100,000$0
Total liabilities$10.0M$2.5M$781,609$12.5M$10.6M$103,234$5.0M
Shareholders' equity
Common stock & paid-in capital$57.1M$30.5M$18.8M$194,538$194,538$88,754$18,354
Retained earnings (deficit)−$64.3M−$28.9M−$17.7M−$12.4M−$10.7M−$10.3M−$12.2M
Accumulated other comprehensive income$10,880——————
Minority interest$104,865$0—————
Total shareholders' equity−$67,554$3.1M$1.1M−$12.2M−$10.5M−$62,651−$2.0M
Key figures
Total debt$4.0M$322,268—$1.5M$667,931—$2.3M
Net cash (debt)$4.7M$3.8M—−$1.3M−$589,417—−$2.3M
Working capital−$47,418$3.1M$1.1M−$12.2M−$10.5M$37,349−$1.4M
Tangible book value−$67,554$3.1M$1.1M−$12.2M−$10.5M−$62,651−$2.0M
Book value per share−$0.20——————
Shares outstanding346K——————
Current ratio1.002.332.420.020.0112.550.68
Quick ratio0.881.812.200.020.0112.550.43
Debt / equity—0.10—————
Equity / assets−0.7%55.5%58.7%−4,315.6%−13,380.6%−154.4%−66.7%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 25, 2026); data from EODHD.

MDCX financial position

At the end of fiscal 2025 (December 31, 2025), Medicus Pharma had total assets of $10.1 million (up 78.2% from a year earlier), total liabilities of $10.0 million and shareholders' equity of -$0.1 million. It held $8.7 million in cash and short-term investments against $4.0 million of debt, a net cash position of $4.7 million. Its current ratio was 1.00. In the latest quarter (ended June 30, 2026) total assets were $19.1 million and equity -$1.2 million.

Related: MDCX income statement, MDCX cash flow statement, MDCX key metrics. See the MDCX stock overview for the latest quote and news.

MDCX balance sheet FAQ

What are Medicus Pharma's total assets?

Medicus Pharma reported total assets of $10.1 million at the end of fiscal 2025 (December 31, 2025), compared with $5.6 million a year earlier.

How much debt does Medicus Pharma have?

Medicus Pharma had $4.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Medicus Pharma have?

Medicus Pharma held $8.7 million in cash and short-term investments at the end of fiscal 2025; with $4.0 million of debt that is net cash of $4.7 million.

What is Medicus Pharma's book value?

Medicus Pharma's shareholders' equity (book value) was -$0.1 million at the end of fiscal 2025, or −$0.20 per share.

What is Medicus Pharma's current ratio?

Medicus Pharma had current assets of $9.9 million and current liabilities of $9.9 million, a current ratio of 1.00 (current liabilities exceed current assets).

Drug Manufacturers - General: balance sheet